文献速递类风湿关节炎

类风湿关节炎中的自身抗体应答:其独特性何在

The Autoantibody response in rheumatoid arthritis; what makes it unique?
PubMed 文献 · Semin Arthritis Rheum · 2025-02-26

本文为综述,讨论类风湿关节炎(RA)中针对翻译后修饰蛋白的自身反应性B细胞应答,重点阐述抗瓜氨酸化蛋白抗体(ACPA)的靶抗原、交叉识别人类与微生物修饰蛋白、Fab糖基化、耐受检查点及分泌型ACPA库的多克隆性与克隆优势,揭示ACPA应答的复杂性与演化特征。

要点

  • ACPA靶向瓜氨酸化蛋白,其存在与更严重的疾病进展相关。
  • ACPA具有高度混杂性,可识别人类与微生物的翻译后修饰蛋白。
  • 分泌型ACPA库高度多克隆、每位患者独特,但由少数ACPA克隆主导。

核心结论

  • ACPA应答在RA中呈现复杂性、高度多克隆性及演化特征,为自身反应性B细胞行为提供了新认识。

研究设计与样本

  • 本文为综述(synopsis),围绕类风湿关节炎中自身抗体应答的既有研究进行汇总讨论,原文未报告检索范围与纳入文献数量。

主要发现

  • ACPA是RA的标志性自身免疫应答,靶向瓜氨酸化蛋白,其存在与更严重的疾病进展相关。
  • ACPA具有高度混杂性,能够识别人类与微生物的翻译后修饰蛋白。
  • ACPA常携带Fab糖基,可能增强B细胞活化或参与耐受机制的逃逸。
  • 尽管受到耐受检查点调控,新技术显示分泌型ACPA库高度多克隆、每位患者独特,但由少数ACPA克隆主导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many autoimmune diseases respond well to therapies targeting B cells, emphasizing the importance of autoreactive B cells in disease induction and progression. In some cases, autoantibodies from plasma cells are the main effectors, while in others, memory B cells are thought to modulate inflammatory responses through antigen presentation or cytokine secretion. Tolerance mechanisms usually prevent the development of autoantibodies, but when these systems fail, autoimmunity and subsequent autoimmune diseases can arise. Understanding the dynamics of autoreactive B cell responses is crucial for delineation the pathogenic pathways underlying disease. Rheumatoid arthritis (RA) is a prototypic autoimmune disease featuring autoreactive B cell responses against post-translationally modified (PTM) proteins. Especially, the Anti-Citrullinated Protein Antibody (ACPA) response, the autoimmune response hallmarking RA, is well characterized over the last two decades. ACPA target citrullinated proteins and their presence is associated with more severe disease progression. In recent years, it has become apparent that ACPA are very promiscuous and able to recognize both human and microbial PTM proteins. Likewise, it is now clear that these antibodies often carry Fab glycans that could, potentially, boost B cell activation and/or be involved in evasion of tolerance mechanisms. Although subjected to tolerance checkpoint, new technologies have shown that the secreted ACPA repertoire is highly polyclonal, unique to each patient, but also dominated by a few ACPA clones. In this synopsis, these and other findings are discussed. Overall, these shed light on the complexity and evolving nature of the ACPA response in RA, unveiling new insights into autoreactive B cell behavior.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Toes REM. The Autoantibody response in rheumatoid arthritis; what makes it unique? Semin Arthritis Rheum. 2025. PMID: 40044517. doi:10.1016/j.semarthrit.2025.152699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。